0001209191-22-007506.txt : 20220207
0001209191-22-007506.hdr.sgml : 20220207
20220207170932
ACCESSION NUMBER: 0001209191-22-007506
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220204
FILED AS OF DATE: 20220207
DATE AS OF CHANGE: 20220207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Drygin Denis
CENTRAL INDEX KEY: 0001819692
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35670
FILM NUMBER: 22598420
MAIL ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE, SUITE 225
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Regulus Therapeutics Inc.
CENTRAL INDEX KEY: 0001505512
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264738379
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4224 CAMPUS POINT COURT
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-202-6300
MAIL ADDRESS:
STREET 1: 4224 CAMPUS POINT COURT
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-04
0
0001505512
Regulus Therapeutics Inc.
RGLS
0001819692
Drygin Denis
C/O REGULUS THERAPEUTICS
4224 CAMPUS POINT COURT #210
SAN DIEGO
CA
92121
0
1
0
0
Chief Scientific Officer
Common Stock
2022-02-04
4
P
0
23314
0.23
A
23314
D
Christopher Aker, Attorney in Fact
2022-02-07